CompletedNo phase
Observational Study of LUMRYZ in Narcolepsy
Key facts
- Who runs it
- Avadel
- Where
- Abington, Bradenton, Cleveland, Columbia, Dublin, East Lansing, East Syracuse, Middletown, Sugar Land, Tomball, Wynnewood, and Wyomissing, United StatesSee the 12 sites
- Trial code
- Status
- Completed
- People taking part
- 71 people enrolled
- Started
- 18 Jul 2024
- Ended
- 28 Oct 2025
- Type of study
- Observational
- Treatments tested
- LUMRYZ
- Record updated
- 13 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adults with narcolepsy
- Oxybate naive or prior treatment with twice-nightly oxybate
- Access to smart phone, tablet or laptop with reliable internet connection
- Able to read/understand English
- Written informed consent and ability to comply with schedule
Who cannot take part
- Clinical or mental health condition excluded by LUMRYZ label
- Any other condition/situation that would adversely impact participation
- Already using LUMRYZ
Where in United States
- Abington Neurological AssociatesAbington, United StatesNo longer taking part
- Jeremy D McConnell, MD PABradenton, United StatesNo longer taking part
- University Hospitals Cleveland Medical Center*Cleveland, United StatesNo longer taking part
- Bogan Sleep ConsultantsColumbia, United StatesNo longer taking part
- Ohio Sleep Medicine InstituteDublin, United StatesNo longer taking part
- Comprehensive Sleep CenterEast Lansing, United StatesNo longer taking part
- Ghaly Sleep Management ServicesEast Syracuse, United StatesNo longer taking part
- Patient First MDMiddletown, United StatesNo longer taking part
- Tricoastal Narcolepsy and Sleep Disorder CenterSugar Land, United StatesNo longer taking part
- Northwest Houston NeurologyTomball, United StatesNo longer taking part
- Pulmonology Associates Inc.Wynnewood, United StatesNo longer taking part
- Respiratory SpecialistsWyomissing, United StatesNo longer taking part
About the trial
What the trial wants to find out
This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.
The group in the trial
- Patients Starting LUMRYZ
The cohort is comprised of patients prescribed LUMRYZ in clinical practice. All dosing decisions are made by the clinician.
Treatment: LUMRYZ
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Prospective, Multicenter, Observational Study of LUMRYZ Used in Clinical Practice for the Treatment of Narcolepsy
- Record updated
- 13 February 2026